Upload
others
View
9
Download
0
Embed Size (px)
Citation preview
Naohiro Terada, M.D., Ph. D. April, 2018
1
Curriculum Vitae
Naohiro Terada, M. D., Ph. D.
Education:
1981 Osaka University, Osaka, Japan, M. D. (Ph. D. Degree was awarded in 2001)
1981-1984 Rotating Resident, Osaka University Hospital etc., Osaka, Japan
1984-1985 Resident in Pediatrics, Osaka Children's Medical Center, Osaka, Japan
1985-1987 Staff in Pediatrics, Osaka Police Hospital, Osaka, Japan
1987-1989 Research Fellow in Pediatrics, Osaka University, Osaka, Japan (Mentor: Keisei Kawa-Ha)
1988-1989 Research Fellow in Oncogene Research, Osaka University, Osaka, Japan (Mentor: Takeo Kakunaga)
1989-1992 Research Associate in Pediatrics, National Jewish Medical and Research Center, Denver, Colorado
(Mentor: Erwin W. Gelfand)
Professional Appointments:
1992-1999 Assistant Faculty Member, Division of Basic Sciences, Department of Pediatrics, National Jewish
Center Medical and Research Center, Denver, Colorado
1994-1999 Adjunct Assistant Professor, Department of Pediatrics (Division of Hematology/Oncology),
Department of Immunology, University of Colorado, School of Medicine, Denver, Colorado
2000-2001 Assistant Professor (Tenure Track), Department of Pathology, Immunology and Laboratory
Medicine, University of Florida College of Medicine, Gainesville, Florida
2001-2010 Associate Professor (with Tenure), Department of Pathology, Immunology and Laboratory Medicine,
University of Florida College of Medicine, Gainesville, Florida
2010-date Professor (with Tenure), Department of Pathology, Immunology and Laboratory Medicine,
University of Florida College of Medicine, Gainesville, Florida
2010-date Visiting Professor, Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University
2013-date
2015-date
Adjunct Professor, Department of Molecular Pathology, Tokyo Medical University
Courtesy Affiliate Professor, Department of Small Animal and Clinical Sciences, College of
Veterinary Medicine, University of Florida
License:
Japanese Medical License, Registration No. 260174
Professional Service and Committees:
National Service
Organizer American Society for Cell Biology Summer Meeting, “Signal Transduction Determining the Fate of
Stem Cells” at Montana State University, Bozeman, MT (2003)
Associate Editor Laboratory Investigation (2003-2008)
Ad Hoc Member NIH Study Section, NIDCR, Special Emphasis Panel (ZDE1, RFA DE-05-005) (2004)
Ad Hoc Member NIH Study Section, NIAMS, Special Emphasis Panel (ZAR1) (2004)
Ad Hoc Member NIH Study Section, NINDS, Special Emphasis Panel (RFA NS-05-005) (2005)
Ad Hoc Member NIH Study Section, DEV2, Ad-Hoc (2005)
Member ISSCR 4th Annual Meeting Abstract Review Sub-Committee (2006)
Ad Hoc Member NIH Study Section, BTSS, Ad-Hoc (2007)
Ad Hoc Member NIH Study Section, Special Emphasis Panel (RG1-BDA-A (58)R) (2009)
Moderator Cardiac Regeneration/Cellular Therapy Scientific Session, American Heart Association,
Annual Meeting (2007)
Co-Director Southeast Stem Cell Consortium (2007-date)
Editorial Board Laboratory Investigation (2008-2011)
Vice Chair 1st Southeast Stem Cell Consortium Workshop (2008)
Naohiro Terada, M.D., Ph. D. April, 2018
2
Ad Hoc Member NIH Study Section, RFA OD09-003 Challenge Grant Panel #10 (ZRG1-BDA-A (58)R)
(2009)
Editorial Board Stem Cells (2009-date)
Ad Hoc Member NIH Study Section, DEV2, Ad-Hoc (2009)
Chair 2nd Southeast Stem Cell Consortium Workshop (2009)
Ad Hoc Member NIH Study Section, Special Emphasis Panel (ZRG1 BDA-P (90) S) (2010)
Ad Hoc Member NIH Study Section, DEV2, Ad-Hoc (2010)
Ad Hoc Member NIH Study Section, DEV2, Ad-Hoc (2011)
Ad Hoc Member NIH Study Section, Special Emphasis Panel (CHHD-C Dev Biol) (2011)
Ad Hoc Member NIH Study Section, Special Emphasis Panel (WNPRC SEP) (2012)
Charter Member NIH Study Section, DEV2 (2013-2017)
Member Pharmacogenomics Research Network (PGRN) Steering Committee (2016-2017)
International Mentor Tokyo Medical University (2016-date)
Institutional Service
Member Admissions Committee, Interdisciplinary Program in Biomedical Sciences, University of
Florida College of Medicine (2000-2003)
Founding Member Program in Stem Cell Biology and Regenerative Medicine, University of Florida (2000-
present)
Reviewer Howard Hughes Medical Institute Research Support Program at University of Florida (2001-
2003)
Member Dean’s Advisory Committee for Future Research Development, University of Florida College
of Medicine (2003-2005)
Member Faculty Search Committee: Epigenetics, University of Florida College of Medicine (2004-
2006)
Member Institutional BIOSAFETY Committee, University of Florida (2009-2013)
Commencement Marshal University of Florida College of Medicine (2009-2011)
Director Center for Cellular Reprogramming, University of Florida (2010-date)
Member Committee for Postdoctoral Fellows, Junior Faculty Career Development, Division of
Experimental Pathology (2010-2011)
Reviewer UF internal selection process for the Searle Scholars Program (2011)
Secondary Mentor Mentoring Committee for Dr. Shin-ichi Someya, Department of Aging and Geriatric Research
(2012-2015)
Co-Primary Mentor Mentoring Committee for Dr. Anna-Maria Joseph, Pepper Scholar (2012-2015)
Member Faculty Search Committee, Pediatrics Hem/Onc, The faculty requisition #0903178 (2013)
Co-Mentor Mentoring Committee for Dr. Guangbin Xia, Department of Neurology (2016-2017)
Director Division of Experimental Pathology, Department of Pathology, Immunology and Laboratory
Medicine, University of Florida College of Medicine (2017-date)
Reviewer University of Florida Opportunity Fund (2018)
Societies/Membership:
American Association for the Advancement of Science (1994~)
American Society for Cell Biology (1999~)
International Society of Stem Cell Research (2002~)
Patents:
Co-Inventor, No. 5504093 "Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for
inhibition of DNA virus replication," issued on April 2, 1996
Co-Inventor, No. 5670520 “Method for inhibiting virus replication in mammalian cells using carbostyil derivatives,” issued
on September 23, 1997
Co-Inventor, No.7601525 “Novel tissue engineered scaffolds from copper capillary alginate gels,” issued on
October 13, 2,009
Naohiro Terada, M.D., Ph. D. April, 2018
3
Review and Referee Activities:
Associate Editor Laboratory Investigation (2003-2008)
Editorial Board Laboratory Investigation (2008-2011)
Editorial Board Stem Cells (2009-present)
Ad Hoc Reviewers Am J Pathol, Am J Physiol, Blood, Development, Exp Cell Res, EMBO J, EMBO R,
Epigenetics, FASEB J, Genes Dev, Gene Therapy, Hepatology, Hypertension, J Biol Chem,
Mech Dev, Mol Cell Biol, Nat Biotech, Nat Cell Biol, Nat Commun, Oncogene, PNAS, PLoS
Biol, Stem Cells, Trends Biotech, Trends Mol Med, etc.
Invited Presentations:
2018/3 Symposium Speaker, UF Regenerative Medicine Conference, Orlando, FL
2018/1 Session Speaker, World Stem Cell Summit, Miami, FL
2017/10 Invited Seminar, Shands Cancer Center, University of Florida
2017/10 Invited Seminar, Reproductive and Perinatal Biology Research Program, University of Florida
2017/9 Invited Seminar, Tokyo Medical University, Tokyo, Japan
2017/6 Invited Seminar, Tokyo Medical and Dental University, Tokyo, Japan
2017/3 Invited Seminar, Yale University, New Haven, CT
2017/3 Invited Seminar, Santa Fe College, Gainesville, FL
2017/1 Invited Seminar, MD/PhD Monthly Educational Dinner, University of Florida
2016/11 Invited Seminar, Nankai University, Tianjin, China
2016/10 Invited Webinar, PGRN RIPS
2016/9 Invited Seminar, Department of Anatomy & Cell Biology, University of Florida
2016/7 Invited Seminar, Cleveland Clinic, Cleveland, OH
2016/6 Speaker, Biomedical Explorations Bench to Bedside, Gainesville, Florida
2016/6 Invited Seminar, Tokyo Medical University, Tokyo, Japan
2016/2 Invited Seminar, Tokyo Medical and Dental University, Tokyo, Japan
2016/2 Invited Seminar, Tokyo Medical University, Tokyo, Japan
2016/2 Invited Plenary Lecture, Kinki Pediatric Hematology/Oncology Society, Osaka, Japan
2015/12 Invited Seminar, Department of Aging, University of Florida
2015/11 Invited Seminar, Otsuka Pharmaceutical Inc, Tokushima, Japan
2015/10 Invited Seminar, Department of Physiology, University of Florida
2015/6 Speaker, Biomedical Explorations Bench to Bedside, Gainesville, Florida
2015/1 Invited Seminar, Tokyo Medical and Dental University, Tokyo, Japan
2015/1 Invited Seminar, Osaka City University, Osaka, Japan
2015/1 Invited Seminar, National Research Institute for Child Health and Development, Tokyo, Japan
2014/11 Invited Seminar, Department of Biochemistry, University of Florida
2014/11 Invited Seminar, Medical College of Georgia, Georgia Regents University, Augusta, GA
2014/10 Invited Seminar, Reproductive and Perinatal Biology Research Program, University of Florida
2014/4 Invited Seminar, University of North Carolina, Chapel Hill, NC
2014/1 Invited Seminar, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan
2014/1 Invited Seminar, Tokyo Medical University, Tokyo, Japan
2013/12 Invited Seminar, Shands Cancer Center, University of Florida
2013/1 Invited Seminar, Tokyo Medical University, Tokyo, Japan
2012/11 Symposium Speaker, U01/U54 Contraception Meeting – Baylor College of Medicine – Houston, TX
2012/10 Invited Seminar, Veterinarian Physiological Sciences Seminar, University of Florida
2012/6 Invited Seminar, Otsuka Pharmaceutical Inc, Tokushima, Japan
2012/3 Invited Seminar, Animal Molecular and Cell Biology, University of Florida
2011/11 Invited Seminar, Ehime University, Matsuyama, Japan
2011/11 Invited Seminar, Hyogo University of Health Sciences, Kobe, Japan
2011/11 Invited Seminar, Nankai University, Tianjin, China
2011/11 Invited Seminar, Cha University, Seoul, Korea
2011/11 Invited Seminar, Gachon University, Incheon, Korea
2011/9 Invited Seminar, Otsuka Maryland Research Institute, Rockville, MD
Naohiro Terada, M.D., Ph. D. April, 2018
4
2010/10 Keynote Speaker, International Conference on Systems Biology of Stem Cells, Taipei, Taiwan
2010/7 Invited Symposium Speaker, 3rd Southeast Stem Cell Consortium Workshop, Nashville, TN
2010/3 Invited Seminar, National Research Institute for Child Health and Development, Tokyo, Japan
2010/2 Invited Seminar, Tokyo Medical and Dental University, Tokyo, Japan
2010/2 Invited Seminar, Reproductive and Perinatal Biology Research Program, University of Florida
2009/11 Invited Seminar, Hyogo University of Health Sciences, Kobe, Japan
2008/12 Invited Seminar, University of Colorado, Department of Pediatrics, Denver, CO
2008/10 Invited Symposium Speaker, 1st Southeast Stem Cell Consortium Workshop, Athens, GA
2008/4 Invited Seminar, University of Illinois, Urbana-Champaign, IL
2008/3 Invited Seminar, Tokyo Medical and Dental University, Tokyo, Japan
2007/3 Invited Seminar, Otsuka Pharmaceuticals, Otsu, Japan
2007/3 Invited Seminar, Tokyo Medical and Dental University, Tokyo, Japan
2006/9 Invited Seminar, University of Washington, Seattle, WA
2006/9 Invited Seminar, Animal Molecular and Cell Biology, University of Florida
2006/3 Invited Seminar, Tokyo Medical and Dental University, Tokyo, Japan
2006/2 Invited Symposium Speaker, Keystone Symposium, Santa Fe, NM
2005/12 Invited Symposium Speaker, Florida Genetics 2005
2005/6 Invited Symposium Speaker, Teratology Society, St. Pete, FL
2005/5 Invited Symposium Speaker, American Transplantation Congress, Seattle, WA
2005/3 Invited Seminar, Kyushu University, Fukuoka, Japan
2005/1 Invited Symposium Speaker, Forefront in Nephrology “Stem Cell and Regeneration of the Kidney”,
Karuizawa, Japan
2003/10 Invited Plenary Lecture, Annual Meeting, Korean Society of Medical Biochemistry and Molecular
Biology, Seoul, South Korea
2003/8 Invited Symposium Speaker, American Heart Association Summer Conference “Molecular Mechanisms
of Growth, Death, and Regeneration in the Myocardium: Basic Biology and Insights into Ischemic Heart
Disease and Heart Failure” Snowbird, UT
2003/5 Invited Symposium Speaker, 11th International Symposium “Recent Advances in Hematopoietic Stem
Cell Transplantation”, San Diego, CA
2003/4 Invited Symposium Speaker, Annual Meeting, American Society for Physiology, FASEB Experimental
Biology Meeting, San Diego, CA
2003/3 Invited Plenary Lecture, Annual Meeting, Canadian Society for Transplantation, Lake Louise, Alberta,
Canada
2002/11 Invited Symposium Speaker, 35th Annual Meeting, American Society for Nephrology, Philadelphia, PA
2002/10 Invited Symposium Speaker, 25th Annual Meeting, Japanese Society for Hematopoietic Cell
Transplantation, Osaka, Japan
2002/10 Invited Symposium Speaker, 75th Annual Meeting, Japanese Society of Biochemistry, Kyoto, Japan
2002/10 Invited Symposium Speaker, 2nd Annual Stem Cells & Regenerative Medicine, Strategic Research
Institute, San Diego, CA
2002/9 Invited Symposium Speaker, Functional Proteomics: Advanced technologies for the analysis of cell
function, Tokyo, Japan
2002/7 Invited Seminar, Tokyo Medical and Dental University, Tokyo, Japan
2002/6 Invited Seminar, University of Colorado, Department of Medicine, Denver, CO
2002/4 Invited Seminar, College of Medicine Research Day “Controversies in Medicine” Seminar, Gainesville, FL
2002/3 Invited Seminar, University of Colorado, Department of Pharmacology, Denver, CO
Research Interests:
Pluripotent Stem Cell Biology: Self-Renewal, Differentiation, Reprogramming and Application
Mitochondrial Adenine Nucleotide Translocase (ANT): Differential Function of ANT paralogs in Development
and Diseases
Teaching Activities:
Class Lectures:
2017-date Lecturer - BME6330 “Cell and Tissue Engineering”
Naohiro Terada, M.D., Ph. D. April, 2018
5
2015-date Lecturer - GMS 6001 “Fundamentals of Biomedical Science I”
2013-2015 Lecturer - ANS 6751 “Physiology of Reproduction”
2013-date Lecturer - “Introduction to Stem Cells” (Tokyo Medical University)
2012-date Lecturer - GMS 6421 “Advanced Cell Biology”
2009-2013 Lecturer - ZOO 3603 “Evolutionary Developmental Biology”
2008-2010 Lecturer - GMS 6005 “Fundamentals of Developmental Biology”
2005-date Lecturer - BCH 7412 “Epigenetics of Human Diseases and Development”
2002-date Course Director - GMS 6331 “Basic Stem Cell Biology”
2000-2006 Discussion Leader - POPS at General Pathology and Immunology (for Medical Students) at U. Florida
2001-2003 Lecturer at Ground Rounds - GMS 6005 (Section 7) “Developmental Biology”
Discussion Leader - GMS 6005 (Section 7) “Developmental Biology”
Discussion Leader - GMS 6006 (Section 8) “Immunology & Microbiology”
1994-1995 Lecturer - Graduate Student Immunology Courses (IDPT 7662, 7663), "The Cell Biology of the Immune
System," Department of Immunology, University of Colorado Health Sciences Center
1996-1999 Lecturer - Basic Science Course, "Introduction to Cell Biology," Department of Pediatrics, University of
Colorado Health Sciences Center
Awards for Trainees (during their training period or for their studies accomplished in Terada’s lab.):
2017 Natalie Fredette, Experimental Pathology Innovative Grant
2016-2017 Natalie Fredette, CTSI, Non-Patient Pilot Award
2016 Joonseok Cho, Exemplary Graduate Student Award, Department of Pathology
2016 Joonseok Cho, 1st Place (Health Science), Florida Statewide Graduate Student Research Symposium
2016 Natalie Fredette, UF Postdoc Research Symposium, Best Poster Award
2016 Joonseok Cho, Finalist (Silver Award), 41st Annual Medical Guild Graduate Student Research Competition
2016 Di Xia, University of Florida, University Scholars Program Award
2015 Joonseok Cho, 21st Annual Outstanding International Student Award, University of Florida
2015 Joonseok Cho, Graduate Scholarship Award, Korean-American Scientists Engineers Association, GFC
2015 Natalie Fredette, Experimental Pathology Innovative Grant
2015-2017 Natalie Fredette, NIH Training Grant (T32), postdoc, DK074367
2015 Katherine Santostefano, University of Florida Superior Accomplishment Award
2014 Joonseok Cho, Graduate Scholarship Award, Korean-American Scientists Engineers Association, KUSCO
2014 Nikolett Biel, CTSI, Pilot Project Award
2014 Anastasiya Yakovenko, Accepted in Junior Honors Medical Program
2014 Nikolett Biel, UF Postdoc Research Symposium, Best Poster Award
2014 Bayli DiVita, University of Florida, University Scholars Program Award
2013 Crysta Iv, Accepted in Junior Honors Medical Program
2012 Aline Bonilla, Experimental Pathology Innovative Grant
2011 You-Jin Jang, University of Florida, HHMI Science for Life Award
2011 You-Jin Jang, University of Florida, University Scholars Program Award
2010 Aline Bonilla, Experimental Pathology Innovative Grant
2010 Ken-ichi Shinohara, Experimental Pathology Innovative Grant
2010 Paola Esparragoza, University of Florida, University Scholars Program Award
2009-2010 Takashi Hamazaki, P01 GM085354 (Dalton, PI), pilot project grant
2009 Jeff Brower, Lawrence M. Goodman Summer Research Fellowship
2009-2011 Katherine Hankowski, NIH Training Grant (T32), pre-doc, CA009126
2008 Takashi Hamazaki, Experimental Pathology Innovative Grant
2008 Rebecca Kirschner, American Cancer Society, Summer Research Fellowship
2008 Amy Rosenbluth, University of Florida, University Scholars Program Award
2008 Jeff Brower, Finalist (2nd Prize), 33rd Annual Medical Guild Graduate Student Research Competition
2007 Sarah Kehoe, American Society for Cell Biology (ASCB) Predoctoral Travel Award
2007 Katherine Hankowski, Research Incentive Award, UFCOM
2006 Amar Singh, Finalist (3rd prize), 31st Annual Medical Guild Graduate Student Research Competition
2005-2007 Brad Willenberg, NIH Training Grant (T32), post-doc, CA009126
2005 Nemanja Rodic, Keystone Symposium Scholarship
2004-2006 Amar Singh, AHA Predoctoral Fellowship
2004-2005 Jamie Graddy, American Cancer Society R. G. Thompson Memorial Summer Research Fellowship
Naohiro Terada, M.D., Ph. D. April, 2018
6
2003-2004 Amar Singh, NIH Training Grant (T32), pre-doc, AG00196-15
2003-2005 Jamie Graddy, University of Florida, University Scholars Program Award
2002-2003 Namanja Rodic, Alec Courtelis International Student Academic Award
2001-2002 Pete Piacenti, University of Florida, University Scholars Program Award
2001-2002 Takashi Hamazaki, American Liver Foundation, Postdoctoral Research Fellowship Award
1999 Tetsuo Minamino, American Heart Association, Finalist of Melvin Marcus Young Investigator Awards of
72nd Scientific Sessions (Atlanta)
1998-1999 Tetsuo Minamino, Banyu-Merck, Fellowship Awards in Lipid Metabolism and Atherosclerosis
Postdoctoral Fellows Education:
2018-date Jared Taylor, PhD
2016-2018 Chul Han, PhD currently Postdoc at Dignity Health, Phoenix, AZ
2016-2016 Yohei Tanada, MD/PhD currently Postdoc at King’s College, London
2016-2017 Noriko Watanabe, MD/PhD currently Associate Professor at Tokyo Medical University, Japan
2015-date Natalie C. Fredette, PhD
2014-2015 Nikolett M. Biel, PhD currently Staff Scientist, Otsuka Maryland Research Lab
2013-2014 Chae Ho Lim, PhD currently Postdoc at New York University
2010-2012 Aline Bonilla, PhD currently Senior Andrologist Cell Biologist, Minitube of America, WI
2010-2011 Ken-ichi Shinohara, PhD currently Research Scientist, Chiba University, Tokyo, Japan
2005-2007 Brad Willenberg, PhD currently Assistant Scientist, Internal Medicine, UCF
2005-2005 Young Dong Park, MD/PhD currently Staff Pediatric Oncologist, Osaka Medical Center
2000-2003 Yuka Nakano, MD/PhD currently Staff Psychiatrist, Osaka 2nd Police Hospital
2000-2003 Masahiro Oka, PhD currently Assistant Professor, Osaka University
2000-2003 Takashi Hamazaki, MD/PhD currently Professor, Osaka City University
2000-2003 Masanori Hoki, MD/PhD currently Professor, Osaka Shoin Women’s University
1998-1999 Tetsuo Minamino, MD/PhD currently Professor, Kagawa Medical University
1997-1999 Yasuhiko Iiboshi, MD/PhD currently Director, Surgery, Rinku General Medical Center
1995-1997 Hideki Kawasome, PhD currently Director, 3rd Institute of New Drug Discovery, Otsuka Pharm.
1994-1996 Hirotaka Sugiyama, MD/PhD currently Private Practice
Graduate Students Education:
PhD Thesis Mentor (GMS 7980, 7979)
2012-2016 Joonseok Cho, PhD currently Postdoc at Stanford University (B. Feldman)
2009-2013 Milena Leseva, PhD currently Postdoc at Harvard University (K. Michel)
2008-2013 Chae Ho Lim, PhD currently Postdoc at New York University (M. Ito)
2006-2011 Katherine Hankowski, PhD currently Assistant Scientist at Center for Cellular Reprogramming
2005-2008 Jeff Brower, PhD currently Resident in Radiation Oncology at University of Wisconsin
2004-2007 Sarah Kehoe, PhD currently Genomics Service Manager, Beckman Coulter
2003-2007 Michael Rutenberg, MD/PhD currently Assistant Professor in Radiation Oncology at UF Jacksonville
2003-2006 Amar Singh, PhD currently Assistant Scientist at University of Georgia.
2002-2005 Nemanja Rodic, MD, PhD currently Assistant Professor at University of Florida
2001-2002 Diana Mastalerz, MD currently Anesthesiologist at Lake Cumberland Reg Hp, Kentucky
MS Thesis Mentor (GMS 6905)
2004-2005 Kirk Giesbrandt, MS currently Resident in Radiology in Mayo Clinic, Jacksonville
2003-2005 Amy Meacham, MS currently Sr. Biol. Scientist at U Florida
1995-1997 Philip Papst, MS currently Senior Research Associate, Myogen, Inc
IDP 1st Year Rotation Mentor (GMS 6090)
2016-2017 Leanne Dumeny (Genetics & Genomics), Kevin Yu, Shu Guo
2015-2016 Bayli DiVita, Leanne Dumeny (MD/PhD), Kyle Dyson (summer rotations)
2014-2015 Leah Dannenberg
2013-2014 Ruan Oliveira, Chris Reid
2011-2012 Phil Doerfler, Janneth Oleas, Joon-Seok Cho, Lisa Lawson, Lizzi Butterworth
2010-2011 Leylah Drusbosky, Yun-Jong Park, Daniil Shabashvili
Naohiro Terada, M.D., Ph. D. April, 2018
7
2009-2010 Thu Le Trinh, Hyun Min Jung
2008-2009 Nikolett Molnar, Milena Leseva
2007-2008 Jen Maier, Deniz Ucar, Chae Ho Lim, Reddy Ranjith Sama
2006-2007 Chul Han
2005-2006 Jonathan Verrier, Katherine Hankowski, Dana Pintilie, Kyung Suk Choi
2004-2005 Matt Murawski, Jeff Brower
2003-2004 Jason O’Rourke, Kyung Hee Chang, Arne Heggestad, Sarah Kehoe, Shangli Lian
2002-2003 Amar Singh, Firas Kobeissy, Bei Wang, Youngme Jung, Kwon-Ho Hong
2001-2002 Barry Flanary, Rafal Witek, Nemanja Rodic
2000-2001 Diana Mastalerz, Hui-Jia Dong
Thesis Advisory Committee (GMS 7980, 7979)
2016-2017 Filipa Botelho Moniz PhD Candidate IDP Immunology & Microbiology, UF (Brusko)
2015-2017 Leah Dannenberg MS IDP Genetics, UF (Seaver)
2015-2017 Gavin Golas PhD IDP Immunology & Microbiology, UF (S. Wallet)
2015-2017 Karessa White PhD Speech, Language & Hearing Sciences, UF (Someya)
2015-date Lucas Armitage PhD Candidate IDP Immunology & Microbiology, UF (Wallet)
2014-2018 Ruan Oliveira PhD IDP Genetics, UF (Swanson)
2014-date Luiz Bolfer PhD Candidate Veterinary Medicine, UF (Estrada)
2014-2017 Nihal El Rouby PhD College of Pharmacy, UF (Johnson)
2013-2014 Adam Frock MS IDP Molecular Cell Biology, UF (Petersen)
2013-2015 David Sullivan PhD Biomedical Engineering, UF (McFetridge/Petersen)
2013-2017 Jared Taylor PhD IDP Immunology & Microbiology, UF (Wallet)
2013-2014 Ivan Sosa MS Veterinary Medicine, UF (Estrada)
2012-2017 Colleen Jeffrey PhD IDP Physiology & Pharmacology, UF (Raizada)
2012-2016 Lisa Lawson PhD IDP Genetics, UF (Harfe)
2011-2014 Yun-Jong Park PhD IDP Immunology & Microbiology, UF (Cha)
2010-2013 Mongjen Chen PhD College of Pharmacy, UF (Song)
2010-2014 Anna Denicol PhD Animal Sciences, UF (Hansen)
2010-2011 Yuan Lu MS Medical Sciences Program, UF (Srivastava)
2010-2016 Michael Lewis PhD IDP Genetics, UF (Resnick)
2010-2014 Yiming Yin PhD IDP Immunology & Microbiology, UF (Morel)
2009-2011 Tegan Lavoie MS Medical Sciences Program, UF (Peck)
2009-2012 Wendy Carcamo PhD IDP Molecular Cell Biology, UF (Chan)
2009-2011 Sonisha Warren PhD IDP Physiology & Pharmacology, UF (Kasahara)
2009-2010 Rushi Patel PhD IDP Molecular Cell Biology, UF (Chan)
2008-2013 Yong Hwan Kim PhD IDP Molecular Cell Biology, UF (Oh)
2008-2012 Jen Maier PhD IDP Genetics, UF (Harfe)
2008-2012 Candace Bichsel PhD IDP Genetics, UF (Jin)
2008-2012 Can Zhang PhD IDP Genetics, UF (Zhou)
2008-2012 Will Donelan PhD IDP Molecular Cell Biology, UF (Yang)
2008-2011 Chul Han PhD IDP Physiology & Pharmacology, UF (Oh)
2007-2012 Bing Yao PhD IDP Molecular Cell Biology, UF (Robertson/Chan)
2007-2012 Star Okada PhD IDP Genetics, UF (Chang)
2007-2008 Eun-Ji Lee MS Medical Sciences Program, UF (Oh)
2006-2010 Qien Yang PhD Animal Sciences, UF (Ealy)
2006-2011 Ekta Patel PhD IDP Genetics, UF (Chang)
2006-2011 Kyung-Suk Choi PhD IDP Genetics, UF (Harfe)
2006-2009 Nicole Steiger PhD IDP Molecular Cell Biology, UF (Petersen)
2006-2010 Meryem Cakiroglu PhD IDP Neuroscience, UF (Laywell)
2006-2009 Dana Pintilie PhD IDP Molecular Cell Biology, UF (Petersen)
2006-2007 Alicia Brown MS Medical Sciences Program, UF (Petersen)
2006-2010 Emily Smith PhD IDP Genetics, UF (Resnick)
2005-2013 Matthew Williams PhD Biomedical Engineering, UF (Batich)
2005-2009 Suhasni Gopalakrishnan PhD IDP Biochemistry, UF (Robertson)
2005-2009 Houda Darwiche PhD IDP Molecular Cell Biology, UF (Petersen)
Naohiro Terada, M.D., Ph. D. April, 2018
8
2005-2009 Susan Ellor PhD IDP Molecular Cell Biology, UF (Petersen)
2004-2008 Shangli Lian PhD IDP Molecular Cell Biology, UF (Chan)
2004-2008 Amy K. Chen PhD IDP Neuroscience, UF (Steindler)
2004-2009 Amanda DuBose PhD IDP Genetics, UF (Resnick)
2004-2007 Jennifer LaPlante MD/PhD UF (Petersen)
2003-2007 Kwon-Ho Hong PhD IDP Physiology & Pharmacology, UF (Oh)
2003-2006 Noah Walton PhD IDP Neuroscience, UF (Steindler)
2003-2005 Jason Batler PhD IDP Molecular Cell Biology, UF (Scott)
2002-2005 Steve Guthrie PhD IDP Molecular Cell Biology, UF (Scott)
2002-2006 Jeong Hoon Joo PhD IDP Molecular Cell Biology, UF (Sugrue)
2002-2006 Sean Kearns PhD IDP Molecular Cell Biology, UF (Steindler)
2002-2005 Rafal Witek PhD IDP Molecular Cell Biology, UF (Petersen)
2002-2005 Jie Deng PhD IDP Molecular Cell Biology, UF (Petersen)
2001-2005 Liya Pi PhD IDP Molecular Cell Biology, UF (Petersen)
2001-2006 Donghang Zheng PhD IDP Molecular Cell Biology logy, UF (Petersen)
2001-2005 Roman Alpatov PhD IDP Molecular Cell Biology logy, UF (Sugrue)
2001-2005 Chris Bray MD/PhD UF (Scott)
2000-2002 Frances R. Bahjat PhD IDP Immunology & Microbiology, UF (Moldower)
Undergraduate Students Education:
Research Mentor (BMS 4905)
2016-date Eliyah Malik
2015-2017 Greg Schwab
2014-2017 Di Xia Currently at UCSF
2014-2015 Bayli DiVita Currently in PhD program (IDP) at U Florida
2013-2015 Anastasiya Yakovenko Currently in MD program at U Florida
2013-2014 Alicia Lew Currently in MD program at U South Florida
2012-2012 Jennifer Thompson
2012-2014 Crysta Iv Currently in MD program at U Florida
2011-2013 Michala Lee Currently in MD program at Florida International University
2010-2012 You-Jin Jang
2010-2011 Alice Chow
2009-2011 Jessica Gilbert Currently in PhD program (Horticultural Sciences) at U Florida
2008-2012 Wai-Yee Leung PA at Nova Southeastern University, Neonate Clinics at Woodhull Med Ctr
2008-2012 Paola Esparragoza Currently in MD program at Temple University
2007-2010 Amy Rosenbluth MD at Jefferson University, Resident in General Surgery
2007-2009 Rebecca Kirschner MD at Virginia Tech Carilion School of Medicine
2006-2008 Joshua Rogozinski MD at U South Florida, Resident in Orthopedic Surgery
2006-2007 Ben Rogozinski MD at U Florida, Resident in Orthopedic Surgery
2005-2006 Stacey Stevens MD at UF, Resident in OB/GYN Naval Medical Center San Diego’s Balboa Hp
2005-2006 Shelley Stevens PharmD at UF
2005-2006 Laura Templeton
2005-2006 William Vinh Ngo DO program at Kansas City U
2005-2006 Isaac Boss PhD at UFCOM (IDP), Postdoctoral Fellow at Weill Cornell
2003-2004 Marina Scotti Currently PhD program (IDP) at U Florida
2003-2004 Kirk J Giesbrandt MD at U Miami, Resident in Radiology in Mayo Clinic, Jacksonville
2002-2005 Jamie Graddy MD at U Miami, Resident in Radiology in Mayo Clinic, Jacksonville
2002-2003 Peter Piacenti Founder & President, Give Hope Foundation
2001-2002 Ken-ichi Tagoku
2001 Thomas Russell PhD at UC Berkley
Foreign Medical Student Research Mentor
2018 Yui Miyagi, Mikoto Fujihara, Rina Takahashi (Tokyo Medical University, Japan)
2017 Mai Kasai, Kanami Iwama, Tamaki Nakamura, Monami Hayashi, Ko-ichi Dai, Ryotaro Sekimoto (Tokyo
Medical University, Japan), Airi Yokoyama (Hiroshima University, Japan)
Naohiro Terada, M.D., Ph. D. April, 2018
9
2016 Kohki Ota, Kousuke Nakazawa, Rei Abe, Shota Fukaura, Akiko Kitano (Tokyo Medical University),
Kyoko Matsui (Hiroshima Universiry)
2015 Momo Uchida, Masato Imai, Keiki Oikawa (Tokyo Medical University)
2014 Satoko Tahata (Tohoku University, Japan)
2012 Ryosuke Nakatsubo (Tokyo Medical University)
2012 Ryo Iwase (Tohoku University)
2011 Wakiko Hiranuma (Tohoku University)
2007 Hiroki Kato (Tohoku University)
High School Students Education:
Research Mentor
2005-2006 Raheen Bush
2003-2004 Elizabeth Cook Undergraduate at MIT
Science Fair Judge
2001-2008 Oak Hall High School
Awards:
2017 Term Professorship Award, University of Florida
2014 Doctoral Mentoring Award, University of Florida College of Medicine
2012 Technology Innovator Award, University of Florida
2010-2012 Education Incentive Award, University of Florida
2008-2012 Exemplary Teacher Award, University of Florida College of Medicine
2001 Top 10 Basic Science Teaching Faculty, University of Florida College of Medicine
1996 NIH First Award
Research Grants, Contracts, and Special Grants:
Active:
National Institutes of Health, R24 GM119977-01 (Terada) 20%
“A stem cell tactic to promote personalized medicine"
Principal Investigator, 7/1/16 - 6/30/19
National Institutes of Health, R01 HL064024 (Oh) 10%
“Role of Macrophages in HHT Pathogenesis and Therapy"
Co-Investigator, 7/6/15 - 4/30/19
National Institutes of Health, UC4 DK104194 (Mathews) 10%
“Genetic Regulation of Human Beta Cell Destruction"
Co-Investigator, 9/30/14 - 6/30/19
National Institutes of Health, R03 HD087528-A1 (Cooke) 4.2%
“Membrane estrogen receptor 1 mediation of epigenetic effects of estrogen"
Co-Investigator, 9/1/16 - 8/31/18
Department of Defense, RP161205 (Oh) 5%
"Pathogenesis of vascular malformations in hereditary hemorrhagic telangiectasia:
From disease mechanism to new therapies"
Co-Investigator, 10/1/17 - 9/30/21
American Heart Association, Grant-in-Aid 16GRNT30980002 (Terada) 10%
"A stem cell tactic to promote personalized medicine in hypertension"
Principal Investigator, 7/1/16-6/30/18
American Heart Association, Scientist Development Grant 17SDG33410467 (Pacak) 1%
Naohiro Terada, M.D., Ph. D. April, 2018
10
"Mechanisms of cardiac and skeletal muscle dysfunction in Barth syndrome"
Co-Investigator, 1/1/17 - 12/31/19
Pending:
DoD/ARMI, (Angelini) 10%
“Advanced liver 3-D tissue models for drug development applications to support toxicology, drug metabolism, target ID &
pharmacology"
Co-Investigator, 7/1/18 - 6/30/20 (Stage 1, 1st year approved, not officially activated yet)
National Institutes of Health, R01 GM127898-A1 (Jin) 20%
“High efficiency genome editing tools for pluripotent stem cells"
Co-Principal Investigator, 9/1/18 - 8/31/22 (The original submission score: 24 percentile)
National Institutes of Health, R01 (Maden) 12.5%
“The causes of skin scarring and its resolution"
Co-Principal Investigator, 9/1/18 - 8/31/22
National Institutes of Health, R01 (Yang) 10%
“Functional Elements of the Prader-Willi Syndrome Imprinting Center"
Co-Investigator, 9/1/18 - 8/31/22
National Institutes of Health, R01 (Wendler) 5%
“Influences of prenatal e-cigarette exposure on cardiovascular development and cardiac function in adult offspring"
Co-Investigator, 9/1/18 - 8/31/22
Past:
University of Florida, Research Opportunity Fund (Byrne)
"Gene Therapy Correction of Frataxin Deficiency in Friedreich’s Ataxia"
Co-Investigator, 5/1/15-4/30/17
Clinical and Translational Science Institute (CTSI) (Terada)
“Center for Cellular Reprogramming”
Center Director, 4/1/14-3/30/17
Otsuka Pharmaceutical Inc. (Terada)
“ANT2 and Cancer"
Principal Investigator, 8/15/11-8/14/16
National Institutes of Health, U01 GM074492 (Johnson)
“Pharmacogenomic Evaluation of Antihypertensive Responses"
Pilot Project Leader, 10/1/13-7/31/16
Thermo/Life Technologies (Terada)
“Generation of cardiomyocytes from disease-associated iPSC lines”
Principal Investigator, 11/1/14-4/30/16
ReproCell (Terada)
“A novel protein delivery machinery for directed iPS cell differentiation”
Principal Investigator, 9/1/14-11/30/15
Clinical and Translational Science Institute (CTSI) Pilot Project Award (Biel)
“The use of patient derived iPSC to study the PKC-α gene in hypertension”
Co-Investigator, 7/15/14-7/14/15
University of Florida, Research Opportunity Fund (Petersen)
"Developing a functional bio-artificial liver device utilizing a decellularized matrix as a platform"
Co-Investigator, 5/1/13-4/30/15
National Institutes of Food and Agriculture/USDA, 2011-67015-30688 (Hansen)
“Developmental programming during preimplantation programming"
Co-Investigator, 9/1/11 - 4/15/15
Naohiro Terada, M.D., Ph. D. April, 2018
11
National Institutes of Health, U01 HD060474 (Terada)
“Developing Male Contraceptives by Targeting ANT4"
Principal Investigator, 2/15/09-1/31/15
Florida Department of Health, James and Ester King Research Grant 3KB04 (Terada)
"T3SS-Mediated Cardiomyocyte Engineering"
Principal Investigator, 7/1/13-12/31/14
Sanford Burnham Research Institute (Terada)
“Inherited Orphan Muscle Diseases”
Consultant, 3/1/14-10/31/14
Department of Pathology, Experimental and Clinical Collaborative Award (ECCA) (Terada, Liu)
"Generation of iPSCs from Primary Pancreatic Cancer to Recapitulate Early Stages of the Disease"
Principal Investigator, 10/1/13-9/30/14
Clinical and Translational Science Institute (CTSI) Novel Technologies Award (Jin)
“A Novel Protein Delivery Technology for Cellular Reprogramming”
Co-Investigator, 6/1/13-5/31/14
Clinical and Translational Science Institute (CTSI) Novel Technologies Award (Terada)
“Generation of Disease-Affected Cell Types from Patient iPS Cells for Clinical Translational Research”
Principal Investigator, 6/1/12-5/31/13
National Institutes of Health, RC1 GM091238-01 (Terada/Jin/Hamazaki)
“iPSC generation using protein injection and site-selective HDAC inhibition"
Contact Principal Investigator, 9/30/09-8/31/12
University of Florida Faculty Enhancement Opportunity (FEO) Award (Terada)
Principal Investigator, 3/1/11-2/28/12
National Institutes of Health, U01 HD060474-02S1 (Terada)
"Developing Male Contraceptives by Targeting ANT4"
Principal Investigator, 9/1/10-8/31/12
University of Florida IFAS Research Innovation Grant (Hansen)
“Development of Pluripotent Stem Cells in Cattle”
Co-Investigator, 11/1/10-10/31/11
Otsuka Pharmaceutical Inc. (Terada)
"Small compounds inhibiting ADP/ATP exchange through ANT2"
Principal Investigator, 4/1/08-3/31/11
University of Florida, Research Opportunity Fund (Jin)
"Bacteria Mediated Delivery of Reprogramming Factors"
Co-Investigator, 5/1/09-4/30/11
Wyeth Pharmaceuticals Protocol #0648G1-4469 (Terada)
"Inhibition of PI3K/Akt/mTOR Pathway by Rapamycin and Its Effect on Liver Fibrosis"
Principal Investigator, 3/1/09-2/28/10
National Institutes of Health, R01 DK065096 (Petersen)
"Stem Cells in Liver Regeneration: Fusion or Plasticity"
Co-Investigator, 9/15/05-6/30/10
National Institutes of Health, P01 GM085354 (Dalton)
"Understanding mechanisms of hESC self-renewal and cell fate commitment"
Pilot Project "Facilitating cardiac differentiation of hESCs by -catenin modulation"
Pilot Project PI, 12/1/08-7/31/09
McKnight Brain Institute (Terada)
"MicroRNAs in Adult Organ Homeostasis, Regeneration and Aging"
Principal Investigator, 2/1/08-1/31/09
Naohiro Terada, M.D., Ph. D. April, 2018
12
UF center for the Cardiovascular Cell Therapy Research Network (Terada)
"Nkx2.5-Positive Cardiac Progenitors in Spleen and Bone Marrow"
Principal Investigator, 10/1/07-9/30/08
Florida Department of Health, Bankhead-Coley Biomedical Research Grant 06BCBG1-22 (Terada)
"Myelodysplastic syndrome, Dnmt3 and Azacytidine"
Principal Investigator, 1/1/07-3/31/08
McKnight Brain Institute (Terada)
"Epigenetic Modifications of Pluripotent Stem Cell-Specific Genes in Human Cancer"
Principal Investigator, 7/1/05-6/30/07
National Institutes of Health, R01 DK059699 (Terada)
"Generation of Hepatocyte Precursors from Mouse Embryonic Stem Cells"
Principal Investigator, 9/1/00-7/31/06
University of Florida Shands Cancer Center, NCI Program Project Development Award (Terada)
"Myelodysplastic Syndrome, DNA Methylation and Azacytidine"
Principal Investigator, 7/1/05-6/30/06
American Heart Association, Grant-in-Aid Florida/Puerto Rico Affiliate, 0455398B (Terada)
"Temporal and lineage-specific modulation of beta-catenin activity to facilitate cardiac differentiation of mouse ES cells"
Principal Investigator, 7/1/04-6/30/06
National Institutes of Health, R13 DK065938 (Terada)
"Signal Transduction Determining the Fate of Stem Cells"
2003 Summer Meeting, The American Society for Cell Biology
Principal Investigator, Conference Chair, 9/20/03-7/31/04
University of Florida, Research Opportunity Fund (Terada)
"Hunting Genes for Somatic Cell Reprogramming"
Principal Investigator, 5/1/03-4/30/04
National Institutes of Health, R21 RR017001 (Terada)
"Generation of Pluripotent Stem Cell Using ES Cell Cytoplast"
Principal Investigator, 4/15/02-3/31/04
National Institutes of Health, R29 CA064685 (Terada)
"p70/85 S6 kinase and selective translational regulation"
Principal Investigator, 7/1/96-4/30/02
VistaGen, Inc. (Terada)
"Development of a Novel Screening System for Expanding Functional Hepatocytes in Differentiating Embryonic Stem
Cells"
Principal Investigator, 4/15/01-3/31/02
Howard Hughes Medical Institute, Biomedical Research Support Program for Medical Schools, UFCM (Terada)
"Role of intracellular signaling molecules in cardiac hypertrophy: Study using embryonic stem cell-derived cardiac
myocytes"
Principal Investigator, 4/1/00-3/31/01
American Heart Association, Grant-in-Aid in Desert/Mountain Affiliate 9951086Z (Terada)
"Cardiomyocyte derived from gene-targeted embryonic stem cells: role of p70 S6 kinase in cardiac hypertrophy"
Principal Investigator, 7/1/99-6/30/01
Cancer League of Colorado (Terada)
"Amino acid dependent control of the mTOR/p70s6k pathway"
Principal Investigator, 7/1/99-6/30/00
Chugai Pharmaceutical Inc. (Terada)
"Effects of nicorandil on vascular remodeling and cardiac hypertrophy through activation of p70 S6 kinase in rabbit with
inhibition of NO synthesis"
Principal Investigator, 4/1/99-3/31/00
Naohiro Terada, M.D., Ph. D. April, 2018
13
Otsuka America Pharmaceutical Inc. (Gelfand/Terada)
"Involvement of adenosine in vesnarinone's biological action, Mechanism of adenosine- and/or allergy-related signal
transduction"
Co-Principal Investigator, 10/1/95-9/30/99
Otsuka Pharmaceutical Co. (Gelfand/Terada)
"Nucleoside and nucleobase transport inhibitors"
Co-Principal Investigator, 10/1/95-9/30/98
Otsuka Pharmaceutical Co. (Gelfand/Terada)
"Inhibition of Cell Cycle Progression by Arkin Z"
Co-Principal Investigator, 10/1/92-9/30/95
American Cancer Society/University of Colorado Cancer Center, IRG 5-33 (Terada)
"Differential effects of rapamycin on p70 S6 kinase phosphorylation and cell proliferation"
Principal Investigator, 9/1/92-8/31/93
Publications:
Refereed Original Articles: (Total Citation: 11633, h-index: 48, i-10 index: 112)
No. Google
Scholar
Citations
Authors, Title, Journal, Volume, Pages, Year, PMCID
128.
Bertholet AM, Fedorenko A, Cho J, Terada N, Wallace DC, Kirichok Y:
Proton transport is an integral function of the mitochondrial ADP/ATP carrier.
Nature In submission
127.
Wang Y, Hao L, Santostefano K, Thapa A, Li H, Guo X, Terada N, Ashizawa T, Valenzuela F, Xia G:
Therapeutic genome editing for myotonic dystrophy type 1 using CRISPR/Cas9.
Mol. Ther. In submission
126.
Takeda K, Ning F, Domenico J, Okamoto M, Ashino S, Kim S-H, Jeong YY, Shiraishi Y, Terada N,
Sutherland ER, Gelfand EW:
Mesenchymal stem cell expression of p70S6 Kinase-1 is essential to lung tissue repair.
Stem Cells Transl. Med. In press, 2018
125.
0
White K, Kim MJ, Han C, Park HJ, Ding D, Boyd K, Walker L, Linser P, Meneses Z, Slade C, Hirst J,
Santostefano K, Terada N, Miyakawa T, Tanokura M, Salvi R, Someya S:
Loss of IDH2 Accelerates Age-related Hearing Loss in Male Mice.
Sci Rep. 8:5039, Mar, 2018 [PMCID: PMC5864918]
124.
0
Taylor JP, Cash MN, Nakanishi M, Santostefano KE, Terada N, Wallet MA:
The interferon-induced protein USP18 is a negative regulator of type 1 IFN and is required for HIV-1
infection in macrophages.
J Leukoc. Biol. In press, 2018 doi: 10.1002/JLB.3MIA0917-352R [PMID 29437254]
123.
0
Jin Y, Liu Y, Li Z, Simmons C, Santostefano KE, Shi J, Zhang X, Wu D, Cheng Z, Wu W, Terada N, Jin S,
Bai F:
Enhanced differentiation of human pluripotent stem cells into cardiomyocytes by bacterial injection of
transcription factor cocktail.
PloS One. 13:e0194895, Mar, 2018 [PMCID: PMC5868831]
122.
1
Ferreira RB, Wang M, Law ME, Davis BJ, Bartley AN, Higgins PJ, Kilberg MS, Santostefano KE, Terada N,
Heldermon CD, Castellano RK, Law BK:
Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive
breast tumor cells.
Oncotarget 8:28971-9, Apr, 2017 [PMCID: PMC5438706]
121.
1
Cho J, Zhang Y, Park SY, Joseph AM, Han C, Park HY, Kalavalapalli S, Chun SK, Morgan D, Kim JS,
Someya S, Mathews CE, Lee YJ, Wohlgemuth SE, Sunny NE, Lee HY, Choi CS, Shiratsuchi T, Oh SP, Terada
N:
Mitochondrial ATP transporter depletion protects mice from liver steatosis and insulin resistance.
Nat. Commun. 8:14477, Feb, 2017 [PMID 28205519]
Naohiro Terada, M.D., Ph. D. April, 2018
14
120.
24
Deng C, Li Y, Zhou L, Cho J, Patel B, Terada N, Li Y, Bungert J, Qiu Y, Huang S:
HoxBlinc RNA recruits Set1/MLL complexes to activate Hox gene expression patterns and mesoderm
lineage development.
Cell Rep. 14:103-14, Jan, 2016 [PMCID:PMC4706800]
119.
1
Zhang Y, Tian D, Matsuyama H, Hamazaki T, Shiratsuchi T, Terada N, Hook D, Walters MA, Georg GI,
Hawkinson JE:
Human adenine nucleotide translocase (ANT) modulators identified by high-throughput screening of
transgenic yeast.
J. Biomol. Screen. 21:381-90, Apr, 2016 [PMID 26746582]
118.
8
Willenberg BJ, Oca-Cossio J, Cai Y, Brown AR, Clapp WL, Abrahamson DR, Terada N, Ellison GW,
Mathews CE, Batich CD, Ross EA:
Repurposed biological scaffolds: Kidney to pancreas
Organogenesis 11:47-57, Apr, 2015 [PMCID:PMC4594556]
117.
8
Gao Y, Guo X, Santostefano KE, Wang Y. Reid T, Zeng D, Terada N, Ashizawa T, Xia G:
Genome therapy of myotonic dystrophy type 1 iPS cells for development of autologous stem cell therapy.
Mol. Ther. 24:1378-87, Aug, 2016 [PMID 27203440]
116.
Hattori T, Hamazaki T, Kudo S, Santostefano KE, Terada N, Shintaku H:
Patient-specific induced pluripotent stem cells to model MELAS/Leigh overlap syndrome with
mitochondrial DNA T10191C mutation. PLoS One In revision
115.
10
Biel NM*, Santostefano KE, DiVita BB, El Rouby N, Carrasquillas S, Simmons C, Nakanishi M, Cooper-
DeHoff RM, Johnson JA, Terada N*:
Vascular smooth muscle cells from hypertensive patient-derived induced pluripotent stem cells to advance
hypertension pharmacogenomics
Stem Cells Transl. Med. 4:1380-90, Dec, 2015 (*co-corresponding authors) [PMCID:PMC4675511]
114.
16
Bai F, Lim CH, Jia J, Santostefano KE, Simmons C, Kasahara H, Terada N*, Jin S*:
Directed differentiation of embryonic stem cells into cardiomyocytes by bacterial injection of defined
transcriptional factors
Sci. Rep. 5:15014, Oct, 2015 (*co-corresponding authors) [PMCID:PMC4598736]
113.
7
Jia J, Bai F, Santostefano KE, Wu D, Wu W*, Terada N*, Jin S*:
Efficient gene editing in pluripotent stem cells by bacterial injection of TALEN proteins
Stem Cells Transl. Med. 4:913-26, Aug, 2015 (*co-corresponding authors) [PMCID:PMC4511150]
112.
12
Cho J, Seo J, Lim CH, Yang L, Shiratsuchi T, Lee MH, Chowdhury RR, Kasahara H, Kim JS, Oh SP, Lee YJ,
Terada N:
Mitochondrial ATP transporter Ant2 depletion impairs erythropoiesis and B lymphopoiesis
Cell Death. Differ. 22:1437-50, Sep, 2015 [PMCID:PMC4532771]
111.
26
Xia G, Gao Y, Jin S, Subramony SH, Terada N, Ranum LPW, Swanson MS, Ashizawa T:
Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent
stem cell-derived neural stem cells.
Stem Cells 33:1829-38, Jun, 2015 [PMCID:PMC4441571]
110.
5
Lim CH, Brower JV, Resnick JL, Oh SP, Terada N:
Ant4 is expressed within embryonic ovaries and dispensable during oogenesis
Reprod. Sci. 22:250-7, Feb, 2015 [PMCID:PMC4287603]
109.
17
Neeld D, Jin Y, Bichsel C, Jia J, Guo J, Bai F, Wu W, Ha UH, Terada N, Jin S:
Pseudomonas aeruginosa injects NDK into host cells through type III secretion system
Microbiol. 160:1417-26, Jul, 2014 [PMCID:PMC4076871]
108.
25
Jia J, Jin Y, Ting B, Wu D, Yang LJ, Terada N, Wu W, Jin S:
Bacterial delivery of TALEN proteins for human genome editing
PLoS One 9:e91457, Mar, 2014 [PMCID: PMC3950253]
107.
8
Chen MJ, Lu Y, Hamazaki T, Tsai HY, Erger K, Conlon T, Elshikha AS, Li H, Srivastava A, Yao C, Brantly M,
Chiodo V, Hauswirth W, Terada N, Song S:
Reprogramming adipose tissue derived mesenchymal stem cells into pluripotent stem cells by a mutant
adeno-associated viral vector
Hum. Gene Ther. Methods 25:72-82, Feb, 2014 [PMCID: PMC3904654]
Naohiro Terada, M.D., Ph. D. April, 2018
15
106.
33
Xia G, Santostefano K, Hamazaki T, Liu J, Subramony SH, Terada N, Ashizawa T:
Generation of human induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro
J. Mol. Neurosci. 51:237-48, Oct, 2013 [PMCID: PMC3608734]
105.
5
Leung WY, Hamazaki T, Ostrov DA, Terada N:
Identification of adenine nucleotide translocase 4 inhibitors by molecular docking
J. Mol. Graph. Model. 45:173-179, Sep, 2013 [PMCID: PMC3821932]
104.
7
Shan J, Hamazaki T, Tang T, Terada N, Kilberg MS:
Activation of the amino acid response modulates lineage specification during differentiation of murine
embryonic stem cells.
Am. J. Physiol. 305:E325-35, Aug, 2013 [PMID: 23736538]
103.
7
Leseva M, Santostefano KE, Rosenbluth A, Hamazaki T, Terada N:
E2f6-mediated repression of the meiotic Stag3 and Smc1β genes during early embryonic development
requires Ezh2 and not the de novo methyltransferase Dnmt3b
Epigenetics 8:873-84, Aug, 2013 [PMCID: PMC3883790]
102.
7
Wang Q, Wang H, Sun Y, Li S-W, Donelan W, Chang L-J, Jin S, Terada N, Cheng H, Reeves W, Yang L-J:
The reprogrammed pancreatic progenitor-like intermediate state of hepatic cells is more susceptible to
pancreatic beta cell differentiation
J. Cell. Sci. 126:3638-48, Aug, 2013 [PMCID: PMC3774026]
101.
25
Xia G, Santostefano K, Goodwin M, Liu J, Subramony SH, Swanson MS, Terada N*, Ashizawa T*:
Generation of Neural Cells from DM1 Induced Pluripotent Stem Cells As Cellular Model for the Study of
Central Nervous System Neuropathogenesis
Cell. Reprogram. 15:166-77, Apr, 2013. [PMCID: PMC3616452] (*co-corresponding authors)
100.
34
Bichsel C, Neeld D, Hamazaki T, Chang LJ, Yang LJ, Terada N, Jin S:
Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein
Cell. Reprogram. 15: 117-25, Feb, 2013 [PMCID: PMC3616421]
99.
12
Della Rocca DG, Willenberg BJ, Ferreira LF, Wate PS, Petersen JW, Handberg EM, Zheng T, Steindler DA,
Terada N, Batich CD, Byrne BJ, Pepine CJ:
A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and
facilitate healing after myocardial infarction.
Med. Hypotheses 79:673-7, Nov, 2012 [PMCID: PMC3725557]
98.
16
Santostefano KE, Hamazaki T, Pardo CE, Kladde MP, Terada N:
Fibroblast Growth Factor Receptor 2 homodimerization rapidly reduces transcription of the pluripotency
gene Nanog without dissociation of activating transcription factors.
J. Biol. Chem. 287:30507-17, Aug, 2012 [PMCID: PMC3436299]
97.
14
Ozawa M, Sakatani M, Hankowski KE, Terada N, Dobbs K, Hansen PJ:
Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell mass cells
of bovine blastocysts for establishment of self-renewing pluripotent cells.
Theriogenology 78:1243-51, Aug, 2012 [PMID: 22898023]
96.
77
Ross EA, Abrahamson DR, St. John PL, Clapp WL, Williams MJ, Terada N, Hamazaki T, Ellison GW, Batich
CD:
Mouse stem cells seeded into decellulalized rat kidney scaffolds endothelialize and remodel basement
membranes
Organogenesis 8:49-55, Apr, 2012 [PMCID: PMC3429512]
95.
71
Carcamo WC, Satoh M, Kasahara H, Terada N, Hamazaki T, Chan JYF, Yao B, Tamayo S, Covini G, von
Mühlen CA, Chan EKL:
Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in
mammalian cells
PLoS One 6, e29690, Dec, 2011 [PMCID: PMC3248424]
Naohiro Terada, M.D., Ph. D. April, 2018
16
94.
47
Pandian GN, Shinohara K, Ohtsuki A, Nakano Y, Masafumi M, Bando T, Nagase H, Yamada Y, Watanabe A,
Terada N, Sato S, Morinaga H, Sugiyama H:
Synthetic small molecules for epigenetic activation of pluripotent genes in mouse embryonic fibroblasts
Chembiochem. 12:2822-8, Dec, 2011 [PMID:22038863]
93.
10
Lim CH, Hamazaki T, Braun EL, Wade J, Terada N:
Evolutionary genomics implies a specific function of Ant4 in mammalian and anole lizard male germ cells.
PLoS One 6:e23122, Aug, 2011 [PMCID: PMC3155547]
92.
13
Hamazaki T, Leung WY, Cain BD, Ostrov DA, Thorsness PE, Terada N:
Functional expression of human adenine nucleotide translocase 4 in Saccharomyces cerevisiae
PLoS One 6:e19250, Apr, 2011 [PMCID: PMC3080916]
91.
6
Willenberg BJ, Zheng T, Meng FW, Meneses JC, Rossignol C, Batich CD, Terada N, Steindler DA, Weiss MD:
Gelatinized copper-capillary alginate gel functions as an injectable tissue scaffolding system for stem cell
transplants.
J. Biomat. Sci. Polym. Ed. 22:1621-37, Apr, 2011 [PMCID: PMC3753783]
90.
28
Bichsel C, Neeld DK, Hamazaki T, Chang LJ, Yang L, Terada N, Jin S:
Bacterial mediated delivery of nuclear protein into pluripotent and differentiated cells
PLoS One 6:e16465, Jan, 2011 [PMCID: PMC3029358]
89.
87
Ge Y, Wu AL, Warnes C, Liu J, Zhang C, Kawasome H, Terada N, Boppart M, Schoenherr CJ, Chen J:
mTOR regulates skeletal muscle regeneration through kinase-dependent and kinase-independent
mechanisms
Am. J. Physiol. 297:C1434-44, Dec, 2009 [PMCID: PMC2793064]
88.
276
Ross E, Williams M, Hamazaki T, Terada N, Clapp W, Adin C, Ellison G, Jorgensen M, Batich C:
Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds
J. Am. Soc. Nephrol. 20:2338-47, Nov, 2009 [PMCID: PMC2799178]
87.
64
Gopalakrishnan S, Van Emburgh BO, Shan J, Su Z, Fields CR, Vieweg J, Hamazaki T, Schwartz PH, Terada
N, Robertson KD:
A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA
methylation patterns and displays altered DNA binding
Mol. Cancer Res. 7:1622-34, Oct, 2009 [PMCID: PMC2783805]
86.
45
Brower JV, Lim CH, Jorgensen M, Oh SP, Terada N:
Adenine nucleotide translocase 4 deficiency leads to early meiotic arrest of murine male germ cells.
Reproduction 138:455-62, Sep, 2009 [PMCID: PMC3727218]
85.
14
Brower JV, Lim CH, Han C, Hankowski KE, Hamazaki T, Terada N:
Differential CpG island methylation of murine adenine nucleotide translocase genes
Biochim. Biophys. Acta 1789:198-203, Mar, 2009 [PMCID: PMC2671066]
84.
23
Kehoe SM, Oka M, Hankowski KE, Reichert N, Garcia S, McCarrey JR, Gaubatz S, Terada N:
A conserved E2F6-binding element in murine meiosis-specific gene promoters
Biol. Reprod. 79:921-30, Nov, 2008 [PMCID: PMC2715002]
83.
321
Singh AM, Hamazaki T, Hankowski KE, Terada N:
A heterogeneous expression pattern for Nanog in embryonic stem cells.
Stem Cells 25:2534-42, Oct, 2007
82.
67
Brower JV, Rodic N, Seki T, Jorgensen M, Fliess N, Yachnis AT, McCarrey JR, Oh SP, Terada N:
Evolutionarily conserved mammalian adenine nucleotide translocase 4 is essential for spermatogenesis
J. Biol. Chem. 282:29658-66, Oct, 2007
81.
48
Lian S, Fritzler, MJ, Katz J, Hamazaki T, Terada N, Satoh M, Chan EKL:
Small interfering RNA-mediated silencing induces target-dependent assembly of GW/P bodies.
Mol. Biol. Cell 18:3375-87, Sep, 2007 [PMCID: PMC1951753]
Naohiro Terada, M.D., Ph. D. April, 2018
17
80.
50
Li F-Q, Singh AM, Mofunanya A, Love D, Terada N, Moon RT, Takemaru K-I:
Chibby promotes adipocyte differentiation through inhibition of -catenin signaling.
Mol. Cell. Biol. 27:4347-54, Jun, 2007 [PMCID: PMC1900052]
79.
80
Singh AM, Li, F-Q, Hamazaki T, Kasahara H, Takemaru K-I, Terada N:
Chibby, an antagonist of the Wnt/β-catenin pathway, facilitates cardiomyocyte differentiation of murine
embryonic stem cells.
Circulation 115:617-26, Feb, 2007 [PMCID: PMC2565513]
78.
34
Willenberg BJ, Hamazaki T, Meng FM, Terada N, Batich CD:
Self-assembled copper-capillary alginate gel scaffolds with oligochitosan support embryonic stem cell
growth
J. Biomed. Mater. Res. 79A:440-50, Nov, 2006
77.
139
Hamazaki T, Kehoe SM, Nakano T, Terada N:
The Grb2/Mek pathway represses Nanog in murine embryonic stem cells.
Mol. Cell. Biol. 26:7539-49, Oct, 2006 [PMCID: PMC1636849]
76.
60
Oka M, Rodic N, Graddy J, Chang L-J, Terada N:
CpG sites preferentially methylated by Dnmt3a
J. Biol. Chem. 281:9901-8, Apr, 2006
75.
77
Zhou H, Liu H, Porvasnik S, Terada N, Agarwal A, Chen Y, Visner GA:
Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary
hypertension
Lab. Invest. 86:62-71, Jan, 2006
74.
89
Rodic N, Oka M, Hamazaki T, Murawski MR, Jorgensen M, Maatouk DM, Resnick JL, Li E, Terada N:
DNA methylation is required for silencing of Ant4, an adenine nucleotide translocase selectively expressed
in mouse embryonic stem cells and germ cells.
Stem Cells 23:1314-23, Oct, 2005
73.
110
Oka M, Meacham AM, Hamazaki T, Rodic N, Chang L-J, Terada N:
De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-
deoxycytidine.
Oncogene 24:3091-9, Apr, 2005 (Covered Article)
72.
7
Nakano Y, Hirko AC, Smith AD, Oka M, Peris J, Dawson R, Terada N, Meyer EM:
Presynaptic dopaminergic properties of differentiated mouse embryonic stem cells
Neurochem. Int. 45:1067-73, Dec, 2004
71.
64
Zhu H, Shang X, Terada N, Liu C:
STAT3 induces anti-hepatitis C viral RNA activity in liver cells.
Biochem. Biophys. Res. Commun. 324:518-28, Nov, 2004
70.
128
Hamazaki T, Oka M, Yamanaka S, Terada N:
Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation.
J. Cell Science 117:5681-6, Nov, 2004
69.
362
Chinzei R, Tanaka Y, Shimizu-Saito K, Hara Y, Kakinuma S, Watanabe M, Teramoto K, Arii S, Takase K, Sato
C, Terada N, Teraoka H:
Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional
hepatocytes.
Hepatology 36:22-9, Jul, 2002
68.
2489
Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott
EW:
Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion.
Nature 416:542-5, Apr, 2002 (Covered Article)
Naohiro Terada, M.D., Ph. D. April, 2018
18
67.
135
Oka M, Tagoku K, Russell T, Nakano Y, Hamazaki T, Meyer EM, Yokota T, Terada N:
CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells.
Mol. Biol. Cell 13:1274-81, Apr, 2002 [PMCID: PMC102268]
66.
122
Minamino T, Yujiri T, Terada N, Taffet GE, Michael LH, Johnson GL, Schneider MD:
MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq.
Proc. Natl. Acad. Sci. USA 99:3866-71, Mar, 2002
65.
99
Sanada S, Kitakaze M, Papst PJ, Asanuma H, Node K, Takashima S, Asakura M, Ogita H,Liao Y, Sakata Y,
Ogai A, Fukushima T, Yamada J, Shinozaki Y, Kuzuya T, Mori H, Terada N, Hori M:
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of
protein kinase A and p38 mitogen-activated protein kinase.
Circulation 104:705-10, 2001
64.
537
Harada H, Andersen J, Mann M, Terada N, Korsmeyer SJ:
P70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
Proc. Natl. Acad. Sci. USA 98:9666-70, 2001
63.
702
Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG:
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase
EMBO J. 20:4370-9, Aug, 2001
62.
530
Hamazaki T, Iiboshi Y, Oka M, Papst PJ, Meacham AM, Zon LI, Terada N:
Hepatic maturation in differentiating embryonic stem cells in vitro.
FEBS Letters 497:15-9, Mar, 2001
61.
131
Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S,
Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M:
Role of phasic dynamism of P38 mitogen-activated protein kinase activation in ischemic preconditioning of
the canine heart.
Circulation Res. 2:175-80, 2001
60.
24
Minamino T, Kitakaze M, Papst PJ, Ueda Y, Sakata Y, Asanuma H, Ogai A, Kuzuya T, Terada N, Hori M:
Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy
associated with the activation of p70 S6 kinase in rats.
Cardiovasc Drugs Ther. 14:533-42, Oct, 2000
59.
7
Minamino T, Kitakaze M, Ueda Y, Asanuma H, Papst PJ, Kuzuya T, Terada N, Hori M:
Chronic treatment with FK506 increases p70 S6 kinase activity associated with reduced nitric oxide
synthase activity in rabbit hearts.
Cardiovasc Drugs Ther 14:329-36, Jun, 2000
58.
15
Sakata N, Hamelmann E, Siadak AW, Terada N, Gerwins P, Aruffo A, Johnson GL, Gelfand EW:
Differential regulation of CD40-mediated human B cell responses by antibodies directed against different
CD40 epitopes.
Cell Immunol. 201:109-23, 2000
57.
11
Sakata N, Kawasome H, Terada N, Johnson GL, Gelfand EW:
CD40 and adenosine A2 receptor agonist/cyclic AMP rescue B cell antigen receptor induced apoptosis via
independent pathways.
J. Allergy Clin. Immunol. 105:522-31, 2000
56.
154
Minamino T, Yujiri T, Papst PJ, Chan ED, Johnson GL, Terada N:
MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes.
Proc. Natl. Acad. Sci. USA 96:15127-32, Dec, 1999
55.
147
Lee-Fruman KK, Kuo CJ, Lippincott J, Terada N, Blenis J:
Characterization of S6K2, a novel kinase homologous to S6K1.
Oncogene 18:5108-14, 1999
Naohiro Terada, M.D., Ph. D. April, 2018
19
54.
57
Iiboshi Y, Papst PJ, Hunger SP, Terada N:
L-asparaginase inhibits the rapamycin-targeted signaling pathway.
Biochem. Biophys. Res. Commun. 260:534-9, Jul, 1999
53.
22
Fujita M, Norris DA, Yagi H, Walsh P, Morell JG, Weston WL, Terada N, Bennion SD, Robinson W, Lemon
M, Maxwell IH, Yohn JJ:
Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-
independent growth in vitro and induces tumour formation and cachexia in vivo.
Melanoma Res. 9:279-91, 1999
52.
81
Schwab MS, Kim SH, Terada N, Edfjäll C, Kozma SC, Thomas G, Maller JL:
The p70s6k controls selective mRNA translation during oocyte maturation and early embryogenesis in
Xenopus laevis.
Mol. Cell. Biol. 19: 2485-94, Apr, 1999
51.
223
Iiboshi Y, Papst PJ, Kawasome H, Hosoi H, Abraham RT, Houghton PJ, Terada N:
Amino acid-dependent control of p70s6k: Involvement of tRNA aminoacylation in the regulation.
J. Biol. Chem. 274:1092-9, Jan, 1999
50.
33
Sakata N, Kawasome H, Terada N, Gerwins P, Johnson GL, Gelfand EW:
Differential activation and regulation of mitogen-activated protein kinases through the antigen receptor
and CD40 in human B cells.
Eur. J. Immunol. 29:2999-3008, 1999
49.
118
Ishizuka T, Chayama K, Takeda K, Hamelmann E, Terada N, Keller GM, Johnson GL, Gelfand EW:
Mitogen-activated protein kinase activation through Fcε receptor I and stem cell factor receptor is
differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived
mast cells.
J. Immunol. 162:2087-94, Feb, 1999
48.
58
Papst P, Sugiyama H, Nagasawa M, Lucas JJ, Maller JL, Terada N:
Cdc2-cyclin B phosphorylates p70 S6 kinase on Ser411 at mitosis.
J. Biol. Chem. 273:15077-84, Jun, 1998
47.
206
Kawasome H, Papst P, Webb S, Keller GM, Johnson GL, Gelfand EW, Terada N:
Targeted disruption of p70s6k defines its role in protein synthesis and rapamycin sensitivity.
Proc. Natl. Acad. Sci. USA 95:5033-8, Apr, 1998.
46.
60
Ishizuka T, Kawasome H, Terada N, Takeda K, Gerwins P, Keller GM, Johnson GL, Gelfand EW:
Stem cell factor augments FcεRI-mediated TNF-α production and stimulates MAP kinases via a different
pathway in MC/9 mast cells.
J. Immunol. 161:3624-30, Oct, 1998.
45.
45
Jeppson JD, Patel HR, Sakata N, Domenico J, Terada N, Gelfand EW:
Requirement for dual signals by anti-CD40 and IL-4 for the induction of nuclear factor-κB, IL-6, and IgE
in human B lymphocytes.
J. Immunol. 161:1738-42, 1998.
44.
13
Kitakaze M, Fong M, Yoshitake M, Minamino T, Node K, Okuyama Y, Terada N, Kambayashi T, Hori M:
Vesnarinone inhibits adenosine uptake in endothelial cells, smooth muscle cells and myocytes, and
mediates cytoprotection.
J. Mol. Cell. Cardiol. 29:3413-7, 1997.
43.
143
Ishizuka T, Terada N, Gerwins P, Hamelmann E, Oshiba A, Fanger GR, Johnson GL, Gelfand EW:
Mast cell tumor necrosis factor production is regulated by MEK kinases.
Proc. Natl. Acad. Sci. USA 94:6358-63, 1997.
42.
10
Sugiyama H, Papst P, Fujita M, Gelfand EW, Terada N:
Overexpression of wild type p70 S6 kinase interferes with cytokinesis.
Oncogene 15:443-52, Jul, 1997.
Naohiro Terada, M.D., Ph. D. April, 2018
20
41.
53
Ishizuka T, Sakata N, Johnson GL, Gelfand EW, Terada N:
Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid
cells.
Biochem. Biophys. Res. Commun. 230:386-91, 1997.
40.
30
Sugiyama T, Papst P, Gelfand EW, Terada N:
p70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr229.
J. Immunol. 157:656-60, Jul, 1996.
39.
10
Takase K, Kelleher CA, Terada N, Jones JF, Lucas JJ, Gelfand EW:
Dissociation of EBV genome replication and host cell proliferation in anti-IgG-stimulated Akata cells.
Clin. Immunol. Immunopathol. 81:168-74, Nov, 1996.
38.
4
Franklin RA, Sawami H, Terada N, Lucas JJ, Gelfand EW:
Activation of p42erk2 MAPK and p90rsk by IL-2 occurs independently of protein kinase C.
Clin. Immunol. Immunopathol. 80:116-22, Aug, 1996.
37.
11
Patel HR, Terada N, Gelfand EW:
Rapamycin-sensitive phosphorylation of ribosomal protein S17 by p70s6k.
Biochem. Biophys. Res. Commun. 227:507-12, Oct, 1996.
36.
73
Ishizuka T, Oshiba A, Sakata N, Terada N, Johnson GL, Gelfand EW:
Aggregation of the FcεRI on mast cells stimulates c-Jun amino terminal kinase activity. A response
inhibited by wortmannin.
J. Biol. Chem. 271:12762-6, 1996.
35.
191
Sakata N, Patel HR, Terada N, Johnson GL, Gelfand EW:
Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells.
J. Biol. Chem. 270:30823-8, Dec, 1995.
34.
78
Terada N, Takase K, Papst P, Nairn AC, Gelfand EW:
Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T
lymphocytes.
J. Immunol. 155:3418-26, 1995.
33.
37
Franklin RA, Brodie C, Melamed I, Terada N, Lucas JJ, Gelfand EW:
Nerve growth factor induces activation of MAP-kinase and p90rsk in human B lymphocytes.
J. Immunol. 154:4965-72, 1995
32.
63
Lucas JJ, Szepesi A, Domenico J, Takase K, Tordai A, Terada N, Gelfand EW:
Effects of iron-depletion on cell cycle progression in normal human T lymphocytes: selective inhibition of
the appearance of the cyclin A-associated comonent of p33cdk2 kinase.
Blood 86:2268-80, 1995
31.
13
Modiano JF, Domenico J, Szepesi A, Terada N, Lucas JJ, Gelfand EW:
Symmetry of the activation of cyclin-dependent kinase in mitogen and growth factor-stimulated T
lymphocytes.
Ann. NY Acad. Sci. 766:134-48, 1995
30.
19
Kumakura T, Takase K, Terada N, Gelfand EW:
Vesnarinone inhibits nucleoside and nucleobase transport.
Life Sciences 57: PL75-81, 1995
29.
30
Lucas JJ, Szepesi A, Domenico J, Tordai A, Terada N, Gelfand EW:
Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2
and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
J. Cell. Physiol. 165:406-16, 1995
28.
25
Franklin RA, Tordai A, Mazer B, Terada N, Lucas JJ, Gelfand EW:
Platelet activating factor activates MAPK and increases in intracellular calcium via independent pathways
in B lymphocytes.
Biochem. Biophys. Res. Commun. 209:1111-8, 1995
Naohiro Terada, M.D., Ph. D. April, 2018
21
27.
10
Takase K, Terada N, Lucas JJ, Gelfand EW:
Control of cell cycle entry and progression in mitogen-stimulated human B lymphocytes.
J. Cell. Physiol. 163:246-55, 1995
26.
27
Franklin RA, Tordai A, Mazer BD, Terada N, Lucas JJ, Gelfand EW:
Activation of MAP2-Kinase in B Lymphocytes by Calcium Ionophores.
J. Immunol. 153:4890-8, 1994
25.
390
Terada N, Patel HR, Takase K, Kohno K, Nairn AC, Gelfand EW:
Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins.
Proc. Natl. Acad. Sci. USA 91:11477-81, Nov, 1994
24.
16
Takase K, Terada N, Szepesi A, Teraoka H, Gelfand EW, Lucas JJ:
Release from G0/G1 arrest induced by dimethyl sulfoxide in human lymphoid cells: Regulation of synthesis
and activation of the p34cdk2 and p34cdc2 kinases.
Cell Growth & Diff. 5:1051-9, 1994
23.
6
Or R, Renz H, Terada N, Gelfand EW:
Regulation of B-cell immune responses: Predominant role of IL-4 in triggering cell proliferation and Ig
production in competent B cells.
Clin. Immunol. Immunopathol. 72:141-9, 1994
22.
10
Patel HR, Renz H, Terada N, Gelfand EW:
Differential activation of p21ras in CD45RA+ and CD45RO+ human T lymphocytes.
J. Immunol. 152:2830-6, 1994
21.
381
Sato N, Sakamaki K, Terada N, Arai K, Miyajima A:
Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common
b subunit responsible for different signaling.
EMBO J. 12:4181-9, Nov, 1993
20.
143
Brodie C, Siriwardana G, Lucas JJ, Schleicher R, Terada N, Szepesi A, Gelfand EW, Seligman P:
Neuroblastoma sensitivity to growth inhibition by deferrioxamine: Evidence for a block in G1 phase of the
cell cycle.
Cancer Res. 53:3968-75, 1993
19.
46
Franklin RA, Mazer B, Sawami H, Mills GB, Terada N, Lucas JJ, Gelfand EW:
Platelet-activating factor triggers the phosphorylation and activation of MAP-2 kinase and S6 peptide kinase
activity in human B cell lines.
J. Immunol. 151:1802-10, 1993
18.
98
Terada N, Franklin RA, Lucas JJ, Blenis J, Gelfand EW:
Failure of rapamycin to block proliferation once resting cells have entered cell cycle despite inactivation of
p70 S6 kinase.
J. Biol. Chem. 268:12062-8, Jun, 1993
17.
8
Saloga J, Schwinzer R, Renz H, Terada N, Or R, Gelfand EW:
Characterization of the progression signal for human T-cell proliferation provided by monoclonal antibodies
to the CD3-TCR complex.
Clin. Immunol. Immunopathol. 67:232-9, 1993
16.
48
Smith TJ, Terada N, Robinson CC, Gelfand EW:
Acute infectious mononucleosis stimulates the expansion of v6.1-3 and v7 T cells.
Blood 81:1521-6, 1993
15.
35
Terada N, Or R, Szepesi A, Lucas JJ, Gelfand EW:
Definition of the roles for iron and essential fatty acids in cell cycle progression of normal human T
lymphocytes.
Exp. Cell. Res. 204:260-7, 1993
Naohiro Terada, M.D., Ph. D. April, 2018
22
14.
185
Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW:
Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to
late G1 phase of the cycle.
J. Cell. Physiol. 154:7-15, 1993
13.
17
Terada N, Or R, Weinberg K, Domenico J, Lucas JJ, Gelfand EW:
Transcription of IL-2 and IL-4 genes is not inhibited by cyclosporin A in competent T cells.
J. Biol. Chem. 267:21207-10, 1992.
12.
21
Or R, Renz H, Terada N, Gelfand EW:
IL-4 and IL-2 promote human T-cell proliferation through symmetrical but independent pathways.
Clin. Immunol. Immunopathol. 64:210-7, 1992
11.
74
Terada N, Lucas JJ, Szepesi A, Franklin RA, Takase K, Gelfand EW:
Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.
Biochem. Biophys. Res. Commun. 186:1315-21, Aug, 1992
10.
36
Lucas JJ, Terada N, Szepesi A, Gelfand EW:
Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation
during cell cycle progression of normal human T cells.
J. Immunol. 148:1804-11, 1992
9.
25
Sawami H, Terada N, Franklin RA, Okawa H, Uchiyama T, Lucas JJ, Gelfand EW:
Signal transduction by interleukin 2 in human T cells: Activation of tyrosine and ribosomal S6 kinases and
cell-cycle regulatory genes.
J. Cell. Physiol. 151:367-77, 1992
8.
70
Terada N, Lucas JJ, Gelfand EW:
Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb)
and p53, during cell cycle progression of normal human T cells.
J. Immunol. 147:698-704, 1991
7.
3
Terada N, Smith TJ, Stork LC, Odom LF, Gelfand EW:
N-ras gene mutations in childhood acute non-lymphoblastic leukemia.
Leukemia Res. 15:935-42, 1991
6.
19
Terada N, Miyoshi J, Kawa-Ha K, Sasai H, Orita S, Yumura-Yagi K, Hara J, Fujinami A, Kakunaga T:
Alteration of N-ras gene mutation after relapse in acute lymphoblastic leukemia.
Blood 75:453-7, 1990
5.
22
Yumura-Yagi K, Hara J, Terada N, Ishihara S, Tawa A, Takihara Y, Champagne E, Minden M, Mak TW,
Kawa-Ha K:
Analysis of molecular events in leukemic cells arrested at an early stage of T-cell differentiation.
Blood 74:2103-11, 1989
4.
28
Hara J, Yumura-Yagi K, Tawa A, Ishihara S, Murata M, Terada N, Izumi Y, Champagne, Takihara Y, Mak
TW, Minden M, Kawa-Ha K:
Molecular analysis of acute undifferentiated leukemia: Two distinct subgroups at the DNA and RNA levels.
Blood 74:1738-46, 1989
3.
3
Tawa A, Kawa-Ha K, Ishihara S, Yumura-Yagi K, Terada N, Murata M, Izumi Y, Yabuuchi H:
T-cell receptor chain gene expression in B-lineage acute lymphoblastic leukemia.
Cancer Science. 79:359-64, 1988
2.
NA
Terada N, Kawa-Ha K, Tawa A, Yagi-Yumura K, Ishihara S, Murata M, Izumi Y, Yabuuchi H, Tsujimoto Y:
The bcl-2 gene in childhood B-lineage acute lymphoblastic leukemia.
J. Clin. Exp. Med. (医学のあゆみ in Japanese), 144:643-4, 1988
1.
10
Taenaka N, Terada N, Takahashi H, Tachimori Y, Okada T, Takezawa J, Shimada Y, Yoshiya I:
Hemodialysis using gabaxate mesilate (FOY) in patients with a high bleeding risk.
Crit. Care. Med. 14:481-3, 1986
Naohiro Terada, M.D., Ph. D. April, 2018
23
Reviews, Book Chapters, Editorial:
No. Times
Cited
Authors, Title, Journal, Volume, Pages, Year
30.
0
Bai F, Li Z, Umezawa A, Terada N, Jin S:
Bacterial Type III Secretion System as a Protein Delivery Tool for a Broad Range of Biomedical
Applications
Biotechnol. Adv. 36:482-93, Mar, 2018 [PMID 29409784]
29.
1
Wallet MA, Santostefano KE, Terada N, Brusko TM:
Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1
Diabetes
Front. Endocrinol. 8:276, Oct, 2017 [PMID:29093700]
28.
0
Watanabe N, Santostefano KE, Yachnis AT, Terada N:
A pathologist’s perspective on induced pluripotent stem cells
Lab. Invest. 97:1126-32, Oct, 2017 [PMID: 28759008]
27.
3
Relling MV, Krauss RM, Roden DM, Klein TE, Fowler D, Terada N, Lin L, Riel-Mehan M, Kubo M, Yee SW,
Johnson G, Giacomini KM:
The New Pharmacogenomics Research Network (PGRN): An open community catalyzing research and
translation in precision medicine
Clin. Pharmacol. Ther. 102:897-902, Dec 2017 [PMID:28795399]
26.
14
Hamazaki T, El Rouby N, Fredette NC, Santostefano KE, Terada N:
Concise Review: Induced pluripotent stem cell research in the era of precision medicine
Stem Cells 35:545-50, Mar, 2017 [PMID:28100040]
25.
10
Kilberg MS, Terada N, Shan J:
Influence of amino acid metabolism on embryonic stem cell function and differentiation
Adv. Nutr. 7:780S-789S, Jul, 2016 [PMID:27422515]
24.
40
Santostefano KE, Hamazaki T, Biel NM, Jin S, Umezawa A, Terada N:
A practical guide to induced pluripotent stem cell research using patient samples
Lab. Invest. 95:4-13, Jan, 2015 [PMID:25089770]
23.
9
Newby B, Terada N, Mathews CE:
In search of a surrogate: Engineering human beta cell lines for therapy
Trends Endocrinol. Metabol. 25:378-80, Aug, 2014 [PMID:24958526]
22.
NA
Hamazaki T, Terada N:
What to be rejuvenated through cellular reprogramming? - Things to consider before jumping on the iPS
cell bandwagon for aging research
Anti-Aging Med. (アンチ・エイジング医学 in Japanese) 8:404-10, June, 2012
21.
NA
Hamazaki T, Terada N:
Disease iPS cells from patients and for patients
Exp. Med. (実験医学 in Japanese) 30:1683-7, June, 2012
20.
NA
Hamazaki T, Terada N:
Current Opinion in patient iPS cell-based disease modeling
J. Clin. Exp. Med. (医学のあゆみ in Japanese) 239:1371-6, Dec, 2011
19.
1
Hankowski KE, Terada N:
An Ezh way to turn off Nanog (News & Views)
Cell Cycle 10:2253-4, July, 2011
Naohiro Terada, M.D., Ph. D. April, 2018
24
18.
23
Hankowski KE, Hamazaki T, Umezawa A, Terada N:
Induced pluripotent stem cell as a next generation biomedical interface
Lab. Invest. 91:972-7, July, 2011 [PMCID: PMC3727242]
17.
2
Crawford JM, Ketcham CM, Braylan RC, Morel L, Terada N, Turner JR, Yachnis AT:
The Publishing Game: Thoughts of an Editorial Team
Lab. Invest. 88:1258-63, Dec, 2008 (Covered Article)
16.
20
Singh AM, Terada N:
Bypassing heterogeneity: the road to embryonic stem cell-derived cardiomyocyte specification.
Trends Cardiovasc. Med. 17:96-101, Apr, 2007 (Covered Article)
15.
17
Oka M, Chang L-J, Costantini F, Terada N:
Lentiviral vector-mediated gene transfer in embryonic stem cells.
In Turksen K, ed. “Embryonic Stem Cell Protocols: Volume I: Isolation and Characterization, Second
Edition” Humana Press, Totowa, New Jersey
Methods Mol. Biol. 329:273-82, Feb, 2006
14.
62
Rodic N, Rutenberg MS, Terada N:
Cell fusion and reprogramming: Resolving our transdifferences
Trends Mol. Med. 10:93-6, Mar, 2004 (Covered Article)
13.
41
Rutenberg MS, Hamazaki T, Singh AM, Terada N:
Stem cell plasticity, beyond alchemy
Int. J. Hematol. 79:15-21, Jan, 2004
12.
NA
Lucas JJ, Terada N:
Chapter 14: Spontaneous cell fusion
In Lanza R et al. Ed. “Adult and Fetal Stem Cells (Vol. 2)” Elsevier Academic Press
Handbook of Stem Cells 2:153-8, 2004
11.
20
Lucas JJ, Terada N:
Cell fusion and plasticity
Cytotechnology 41:103-9, 2003 [PMCID: PMC3466689]
10.
25
Hamazaki T, Terada N:
In vitro differentiation of embryonic stem cells into hepatocytes
Methods Enzymol. 365:277-87, 2003
9.
NA
Kawasome H, Hamazaki T, Minamino T, Terada N:
Signal transduction study using gene-targeted embryonic stem cells.
In Terrian DM, ed. “Cancer Cell Signaling” Humana Press, Totowa, New Jersey
Methods Mol. Biol. 218:35-46, 2003
8.
NA
Mastalerz DM, Terada N:
An “Identity Crisis” for Stem Cells
Directions in Science 1:96-8, 2002
7.
NA
Terada N:
Cell fusion shows a trick of stem cell magic?
Cell Technology (細胞工学 in Japanese) 21:648-9, 2002
6.
31
Petersen BE, Terada N:
Stem cells: A journey into a new frontier
J. Am. Soc. Nephrol. 12:1773-80, 2001 (Covered Article)
5.
NA
Terada N: Cell cycle regulatory genes and malignant tumors: Basic and clinical studies of INK4a.
Jpn. J. Ped. Hematol. (小児血液学雑誌 in Japanese) 11:1-13, 1996.
Naohiro Terada, M.D., Ph. D. April, 2018
25
4.
NA
Terada N: Enigma of The Immunosuppressive Drug, Rapamycin.
Seikagaku (生化学 in Japanese) 67:1241-5, 1995
3.
NA
Terada N: S6 kinase and translational regulation of mRNAs encoding ribosomal proteins.
Exp. Medicine (実験医学 in Japanese) 13:442-5, 1995
2.
4
Terada N, Franklin RA, Lucas JJ, Gelfand EW:
T-cell signalling and activation through the IL-2 receptor complex:
In"Growth Factors and Signal Transduction in Development" Nilsen-Hamilton M., ed. New York, NY:
John Wiley & Sons, Inc. pp75-95, 1994
1.
NA
Terada N, Kawa-Ha K:
Mixed lineage leukemia (biphenotypic leukemia).
Annual Review Ketsueki 1988 (in Japanese), pp65-71, 1988